TK216 is an orally active and potent E26 transformation specific (ETS) inhibitor[1]. TK216 directly binds EWS-FLI1 and inhibits EWS-FLI1 protein interactions. TK216 blocks the binding between EWS-FLI1 and RNA helicase A. TK216 has anticancer activity[2].
Molecular Weight:
376.23
Purity:
99.84
CAS Number:
[1903783-48-1]
Formula:
C19H15Cl2NO3
Target:
DNA/RNA Synthesis
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted